Dhsc_Dfl National Reduce and Reuse Medtech Tender - 146682587

Procurement Summary

Country: United Kingdom

Summary: Dhsc_Dfl National Reduce and Reuse Medtech Products Campaigns 2026

Deadline: 01 Sep 2026

Posting Date: 06 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 146682587

Document Ref. No.: C459541

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

73000000 - Research and development services and related consultancy services
79419000 - Evaluation consultancy services
73210000 - Research consultancy services
79417000 - Safety consultancy services
79410000 - Business and management consultancy services
90713000 - Environmental issues consultancy services

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

The Department of Health and Social Care, working jointly with the Greener NHS team in NHS England, is seeking to appoint a supplier to provide research, analysis, piloting, implementation evaluation and programme support for the Design for Life National Reuse and Reduce MedTech Products Programme. The programme supports the Government's ambition to deliver a circular economy for MedTech products by 2045. The supplier will support selected circular MedTech product initiatives and associated interventions as they move through investigation, piloting, implementation and, where appropriate, wider national rollout. Scope of the requirement 1. recruit, mobilise, brief and support a minimum of 20 NHS Trusts to participate in pilot and implementation activity for priority circular MedTech products, with the ability to accommodate a higher number where required and agreed with the Authority; 2. provide participating organisations with support throughout the development, running and monitoring of pilots, investigations or implementation activity, including conducting quality improvement assessments and capturing relevant data; 3. undertake quality, equality, patient impact, benefits, sustainability, social value and health economic assessments using appropriate recognised methodologies; 4. carry out behavioural insight and adoption assessment work, including identifying barriers and enablers across clinical, estates, commercial, infection prevention and control, and leadership teams; ...

Documents

 Tender Notice